Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json | Help ]

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 1  Agents affecting nervous system and sensory organs
 2  Agents affecting individual organs
 3  Agents affecting metabolism
 4  Agents affecting cellular function
 5  Crude drugs and Chinese medicine formulations
 6  Agents against pathologic organisms and parasites
   61  Antibiotics
     611  Acting mainly on gram-positive bacteria
     612  Acting mainly on gram-negative bacteria
     613  Acting mainly on gram-positive and gram-negative bacteria
     614  Acting mainly on gram-positive bacteria and mycoplasma
       6141  Erythromycins
         D00140  Erythromycin (JP17/USP/INN)
         D01361  Erythromycin ethylsuccinate (JP17/USP)
         D02009  Erythromycin lactobionate (JP17/USP)
         D02184  Erythromycin stearate (JP17/USP)
D10AF02 J01FA01 S01AA17
D10AF02 J01FA01 S01AA17
D10AF02 J01FA01 S01AA17
D10AF02 J01FA01 S01AA17
       6142  Spiramycin antibiotics
       6143  Kitasamycins
       6144  Oleandomycins
       6145  Josamycins
       6146  Midecamycins
       6149  Others
     615  Acting mainly on gram-positive bacteria, gram-negative bacteria, rickettsia and chlamydia
     616  Acting mainly on acid-fast bacteria
     617  Acting mainly on mold
     619  Miscellaneous
   62  Chemotherapeutics
   63  Biological preparations
   64  Parasitics (systemic)
   69  Other agents against pathogenic organisms and parasites
 7  Agents not mainly for therapeutic purpose
 8  Narcotics

Last updated: September 29, 2020
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version